Ct23 what's new in ICU.

Ct23 what's new in ICU. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Ct23 what's new in ICU. Abstract Text:

G M Shaw,

Intensive care medicine is at the intersection of medical, surgical and engineering sciences. While the lion's share of attention in medical research focuses on magic bullets, these have largely failed to deliver in intensive care. Specifically, significant improvements have come from improving what might be regarded as the 'bread and butter' of clinical practice. Improvements the management of sedation, ventilation, glycaemic control, sepsis, shock and renal support have resulted in significant improvements in patient outcomes. Simple measures such as switching off sedation on morning rounds can reduce duration of mechanical ventilation and length of intensive care stay by 32 to 35%(1). Reduction of tidal volumes in acute respiratory distress syndrome (ARDS) from 12 to 6 ml per kilogram has reduced mortality from 39.8% to 31% in a landmark study of 861 patients(2). This is consistent with findings from smaller clinical trials and animal data linking shear forces in the lung, produced by mechanical ventilation, with biological injury. A recent study of 1548 mainly cardiothoracic surgical patients found that intensive insulin therapy reduced intensive care mortality from 8.0% with conventional treatment to 4.6%, with the greatest reduction in death due to multiple-organ failure with a proven septic focus(3). Bloodstream infections, acute renal failure, red-cell transfusions, and critical-illness polyneuropathy were also all reduced by over 40%. Early goal directed therapy reduced in-hospital mortality from 46.5% to 30.5% in a cohort of 263 patients admitted to an emergency department in patients with severe sepsis or septic shock(4). Significant benefits resulted from early resuscitation of shocked patients using predefined protocols. Summary Targeted protocolised therapies across a wide range of intensive care conditions have resulted in the greatest outcome benefits for critically ill patients.

Ct23 what's new in ICU. Publishing Authors By Initials

GM Shaw,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Ct23 what's new in ICU. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: ANZ journal of surgery

VOLUME: 77 Suppl 1

Page Numbers: A12

Journal Abbreviation:

ISSN: 1445-1433

DAY: 10

MONTH: May

YEAR: 2007

Ct23 what's new in ICU. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101086634

Ct23 what's new in ICU. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Ct23 what's new in ICU. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Ct23 what's new in ICU.

AFFILIATION: Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand.

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: ANZ J Surg

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Ct23 what's new in ICU Related Publications

• A cricket Gene Index: a genomic resource for studying neurobiology, speciation, and molecular evolution.
• Age-associated defect in human TLR-1/2 function.
• Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice.
• Biotransformation of maximakinin, a bradykinin-related nonadecapeptide from toad venom, by mammalian kallikrein and salivary proteases.
• Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources.
• Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters.
• Ct05 mechanical valve or tissue valve: do patients regret their decision?
• Ct23 what's new in ICU.
• Ct25 cpap: an overview and current applications.
• Ct27 a history of errors and the christchurch solution.
• Ct32 when to call the surgeon.
• Developmental divergence of sleep-wake patterns in orexin knockout and wild-type mice.
• Do the predictors of child conduct problems vary by high- and low-levels of socioeconomic and neighborhood risk?
• Ending the splits.
• Essentials of sleep recordings in Drosophila: moving beyond sleep time.
• From Sydney to Athens: preparing for the Olympic and Paralympic Games.
• Identification of a biomarker for sleep drive in flies and humans.
• Impact of neighborhood disadvantage on overt behavior problems during early childhood.
• Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study.
• Mitochondrial DNA haplogroups and amyotrophic lateral sclerosis.
• Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults.
• Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study.
• Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
• Synthesis and stereochemical assignment of brasilibactin A.
• Synthesis of kaempferitrin.
• Testing mediators of intervention effects in randomized controlled trials: An evaluation of two eating disorder prevention programs.
• The African orphan crisis and international adoption.
• The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse.
• Ugo1p is a multipass transmembrane protein with a single carrier domain required for mitochondrial fusion.
• [The self-training of a therapist : a demystification process.]